Although science has made great progress against bacterial disease, our advances against viruses are still in their infancy. Now, potentially good news is being reported in the battle against the current pandemic: An experimental oral drug known as molnupiravir reduces the risk of hospitalization and death in phase III clinical trials.
Today Joe Alton MD (aka Dr.Bones) and Nurse Practitioner Amy Alton are going to talk about two products developed by Merck Pharmaceuticals: Ivermectin and Molnupiravir, and the evidence for their effectiveness in the COVID pandemic. Plus, why is Merck pushing this new drug over ivermectin, already FDA approved for certain parasitic issues?
All this and more on the latest episode of the Survival Medicine Podcast with Joe and Amy Alton!
Hey have you gotten a copy of the brand new, greatly expanded 4TH EDITION of the Survival Medicine Handbook? Check it out at store.doomandbloom.net along with our entire line of quality medical kits, individual supplies and personal protection gear (including N95 masks) or go to Amazon.com. You'll be glad you did.
